FDA responds to reports of antiviral rebound infections

Name: FDA responds to reports of antiviral rebound infections
Uploaded: 2022-05-20T21:09:53Z
Duration: 2 min 38 s
Description: With the rise of COVID-19 cases, antiviral medications are becoming prevalent such as Paxlovid. Health officials are now reporting antiviral rebound infections, where symptoms are developed or a test returns as positive days after the five day course of treatment.

With the rise of COVID-19 cases, antiviral medications are becoming prevalent such as Paxlovid. Health officials are now reporting antiviral rebound infections, where symptoms are developed or a test returns as positive days after the five day course of treatment.

Posted May 20, 2022 5:09pm EDT